Kind of.
RAC's SP increase today in response to Trump's proposed price cap while other biotechs are sold off is clearly because the market thinks that the risk of RC220 ever being approved in the USA is low.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.050(3.89%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.21 | $140.6K | 112.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7395 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 18045 | 3 |
View Market Depth
| Last trade - 11.55am 24/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |